A pharmaceutical dosage unit for oral administration to a human female
comprising a therapeutically effective amount of 17.beta.-estradiol-3-low-
er alkanoate, most preferably 17.beta.-estradiol-3-acetate, and a
pharmaceutically acceptable carrier is disclosed. Also disclosed is a
method for treating a human female in need of 17.beta.-estradiol and a
contraceptive method by oral administration of the pharmaceutical dosage
unit and a method of preparing a pharmaceutical composition that may be
used to form the pharmaceutical dosage unit of the invention.